Latest news
Loading news…
Avrion Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Allschwil, Basel-Landschaft, Switzerland Founded 2020 1-10 employees For Profit
Avrion Therapeutics is a precision Gene Therapies for Neurodegenerative Diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $48K
Company Info
- Founded
- 2020
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Allschwil, Basel-Landschaft, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.3
- Trend (90d)
- -0.3
Key People at Avrion Therapeutics
Co-founder and Chairperson of Advisory Board
2
professional contacts at Avrion Therapeutics
Contact execs at Avrion Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Avrion Therapeutics
Loading news…
FAQs about Avrion Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.